Development of a Recovery Oriented Treatment for Post Acute Suicidal Episode (PASE) Veterans
Project Number5IK2RX003571-02
Former Number1IK2RX003571-01A1
Contact PI/Project LeaderSOKOL, YOSEF
Awardee OrganizationJAMES J PETERS VA MEDICAL CENTER
Description
Abstract Text
Mental health care for Veterans with suicidal symptoms is of paramount import to the VA. Unfortunately, VA
suicide reports show suicide rates increasing, suggesting a need for enhancing current VA suicide mental
health care efforts. While several psychotherapeutic treatments exist for acute suicidality, there is a deficit in
validated treatments designed to help Veterans following an acute suicidal episode (Post Acute Suicidal
Episode; PASE) such as following a non-fatal suicide attempt after acute risk declines but when they still have
ongoing mental health needs and, at times, chronic suicidal symptoms. Available suicide treatments are not
designed to promote the recovery and rehabilitation of PASE Veterans. This is a significant gap in
comprehensive suicide-focused mental health care. One avenue to close this gap lies through the
development of a recovery-oriented psychotherapy for PASE Veterans. Developing recovery-oriented care, “a
process of change through which individuals improve their health and wellness, live a self-directed life, and
strive to reach their full potential” is a VA priority; however, available treatments for suicidal Veterans have
limited recovery-orientation. Decades of research into the development of suicide and processes of recovery
highlight the importance of increasing Veterans hopefulness about the future, developing a positive self-
identity, promoting Veterans’ sense of self-empowerment and improved relationships. Continuous Identity-
Cognitive Therapy (CI-CT) is a promising new manualized suicide intervention focused on improving Veterans
sense of their life story and personal future, with goals similar to recovery-oriented care. CI-CT was developed
by the applicant and, as a group therapy, piloted for suicide reduction in Veterans with SMI and was found to
have high levels of feasibility, acceptability and (in exploratory analyses) to lead to increased hopefulness
about the future and decreased suicidal symptoms. However, CI-CT needs further adaptation for use with
PASE Veterans and to enhance its alignment with the fundamentals of recovery-oriented care.
The proposed study has three primary stages:
First: develop an improved recovery-oriented version of the initial CI-CT Clinician Manual and Veteran
workbook to further address components identified as critical for PASE recovery using, (1) an ongoing
stakeholder study into the needs of PASE Veterans, (2) recovery literature, (3) scientific and Veteran consumer
advisory boards and (4) iterative feedback from an online Veteran PASE sample (N=25) on each section of the
workbook. This process will be guided by scientific and PASE Veteran Consumer advisory boards
Second: use the materials developed in phase 1 to run 3 one-arm treatment development trials (each with an
N of 4-6 PASE Veterans) to test and enhance the CI-CT treatment materials using Veteran feedback and
acceptability and feasibility data. Then, with the guidance of our scientific and Veteran consumer advisory
boards, use these results to update the treatment.
Third: conduct a pilot RCT (N=30) comparing CI-CT for PASE Veterans to an AC (health education) to assess
feasibility and acceptability of the treatment materials and research protocol including outcome measures
selected and assessment strategy. We will assess rates of recruitment, intervention engagement, and session
attendance (feasibility), Veteran satisfaction (acceptability), treatment adherence (fidelity) and preliminarily
explore response to CI-CT. Findings will be used to make a final adaptation of the treatment materials and to
develop a research protocol for a large scale RCT of CI-CT for PASE Veterans.
This study will develop and pilot test a well-specified, group-based intervention tailored to the unique needs of
PASE Veterans. The results of the proposed study will provide data to 1) identify adaptations needed to
optimize CI-CT for PASE Veterans: 2) identify possible benefits of CI-CT; 3) inform development of a large
scale RCT of CI-CT for PASE Veterans.
Public Health Relevance Statement
Suicide is a major problem in the Veteran population with 20 Veterans dying by suicide daily. While
psychotherapeutic treatments are available for Veterans during the period of acute suicide risk, there are no
treatments available specifically designed to promote the recovery of Veterans following a suicidal episode.
This is a critical gap in Veteran mental health care and in comprehensive suicide treatment. This study aims to
develop and pilot test a recovery oriented intervention for Veterans who have been acutely suicidal in the past
year but are no longer at high risk. The treatment aim is to promote the Veteran’s development of a positive
self-narrative extending into a vivid and desired future and is designed to closely map onto primary recovery
processes such as increased life meaning, hopefulness, empowerment and improved personal identity. This
project will result in Veteran specific treatment materials and information about the acceptability and feasibility
of this intervention needed for a future large scale intervention trial.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AcuteAddressAftercareAgeAreaCaringChronicClinicalCognitive TherapyConsultDataDepressed moodDepression and SuicideDevelopmentExhibitsFeedbackFeeling hopelessFeeling suicidalFundingFutureGoalsGroup TherapyHealthHealth educationHotlinesHourIndividualInterventionIntervention TrialLeadLengthLifeLiteratureManualsMapsMechanicsMental HealthMental Health ServicesMentorsMonitorNeeds AssessmentOutcomeOutcome MeasureParticipantPersonsPhasePilot ProjectsPopulationProcessProtocols documentationPsychotherapyQuality of lifeRecording of previous eventsRecoveryRecovery of FunctionRehabilitation therapyReportingResearchResearch PersonnelRiskRisk FactorsRoleRunningSafetySamplingSelf EfficacySelf-DirectionSocial NetworkSpecific qualifier valueSuicideSuicide attemptSuicide preventionSymptomsTestingTimeTrainingUpdateVeteransacceptability and feasibilityactive controlarmbasecareerdesigndisabilityempowermentevidence baseexperiencefollow-uphigh riskimplementation scienceimprovedmalemilitary veteranpilot testprimary outcomeprocess repeatabilitypsychoeducationreadmission ratesrecruitresilienceresponseretention ratesatisfactionsecondary outcomesocialsocial relationshipssuicidalsuicidal individualsuicidal risksuicide ratetherapy designtherapy developmenttreatment adherencetreatment armtreatment duration
No Sub Projects information available for 5IK2RX003571-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5IK2RX003571-02
Patents
No Patents information available for 5IK2RX003571-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5IK2RX003571-02
Clinical Studies
No Clinical Studies information available for 5IK2RX003571-02
News and More
Related News Releases
No news release information available for 5IK2RX003571-02
History
No Historical information available for 5IK2RX003571-02
Similar Projects
No Similar Projects information available for 5IK2RX003571-02